GALMED PHARMACEUTICALS
Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, Aramcholâ„¢, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study.
GALMED PHARMACEUTICALS
Industry:
Health Care Medical Pharmaceutical
Founded:
2000-01-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.galmedpharma.com
Total Employee:
11+
Status:
Active
Contact:
+972 3-693-8448
Email Addresses:
[email protected]
Total Funding:
96.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Google Maps JsDelivr Contact Form 7 Google Maps API
Similar Organizations
ZS Pharma
ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.
Current Employees Featured
Founder
Stock Details
Investors List
Meitav Investment House
Meitav Investment House investment in Post-IPO Equity - Galmed Pharmaceuticals
Sphera Funds Management
Sphera Funds Management investment in Post-IPO Equity - Galmed Pharmaceuticals
Official Site Inspections
http://www.galmedpharma.com Semrush global rank: 3.89 M Semrush visits lastest month: 3.28 K
- Host name: 112.114.215.35.bc.googleusercontent.com
- IP address: 35.215.114.112
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Galmed Pharmaceuticals"
About us : Galmed Pharmaceuticals
Galmed started some 20 years ago and has blossomed from a one-man discovery to a passionate global drug development team working on the next generation of metabolic and inflammatory therapeutics programs from …See details»
Galmed Pharmaceuticals - Crunchbase Company …
Contact Email [email protected] Phone Number +972 3-693-8448 Galmed Pharmaceuticals Ltd. is a clinical stage drug development …See details»
Galmed Pharmaceuticals Ltd. - AnnualReports.com
Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Its …See details»
Galmed Pharmaceuticals Company Profile | Management and
Www.galmedpharma.com Galmed Pharmaceuticals Profile and History Galmed Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of Aramcholâ„¢, …See details»
Galmed Pharmaceuticals Ltd. (GLMD)
See the company profile for Galmed Pharmaceuticals Ltd. (GLMD) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Investors Center
Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, Aramcholâ„¢, a backbone drug candidate for the treatment of …See details»
Galmed Pharmaceuticals Ltd. (GLMD) Company Profile & Overview …
Mar 13, 2014 Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in …See details»
Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for …
Shareholders can obtain copies of Galmed's Annual Report on Form 20-F, free of charge, by making a request within a reasonable period of time to Galmed's Investor Relations …See details»
Galmed Pharmaceuticals Ltd. (GLMD) - Yahoo Finance
Find the latest Galmed Pharmaceuticals Ltd. (GLMD) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Galmed Pharmaceuticals Ltd. - Cruelty Free Investing
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of Aramchol, a novel, once-daily, oral therapy for treating …See details»
Galmed Pharmaceuticals Provides Business Update and Reports …
May 2, 2022 - Conference Call and Webcast Today at 8:30 a.m. ET / 5:30 a.m. PT-. TEL AVIV, Israel, May 2, 2022 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) …See details»
Galmed Pharmaceuticals Provides Business Update and Reports …
TEL AVIV, Israel, Aug. 5, 2021 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the …See details»
Investors : Galmed Pharmaceuticals
Jul 17, 2021 Cookie Duration Description; cookielawinfo-checkbox-analytics: 11 months: This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent …See details»
GLMD.O - | Stock Price & Latest News | Reuters
Nov 23, 2024 Get Galmed Pharmaceuticals Ltd (GLMD.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsSee details»
People : Galmed Pharmaceuticals
+25 years of experience in the global financial markets, including significant experience on the buy-side of life sciences companies. Since 2016, Mr. Cohen has served as Chief Executive …See details»
GLMD Stock Price & Charts | Galmed Pharmaceuticals
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and …See details»
Galmed Pharmaceuticals Provides Business Update and Reports …
May 2, 2022 - Conference Call and Webcast Today at 8:30 a.m. ET / 5:30 a.m. PT-. TEL AVIV, Israel, May 2, 2022 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) …See details»
Pipeline : Galmed Pharmaceuticals
Each investigational drug in our pipeline has the potential to change someone’s life, to ease someone’s suffering, to bring someone hope. The potential impact of these drugs on people …See details»
Galmed Pharmaceuticals Provides Business Update and Reports …
Aug 4, 2022 Financial Summary – Second Quarter 2022 vs. Second Quarter 2021: Cash and cash equivalents, restricted cash and marketable debt securities totaled $22.5 million as of …See details»